Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-25

Clinical Trial Update: Effect of Topical Sulforaphane on Skin Fragility Seen in Skin Aging and With Ultraviolet Exposure [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating topical sulforaphane for skin fragility associated with aging and UV exposure was terminated; results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulforaphane (topical) (sulforaphane)

Snippet

Sponsor: Johns Hopkins University | Conditions: Aging | Phase 2 | Status: TERMINATED | Results posted: 2020-02-25